Dividend Track Records

Preferred Bank (PFBC) will raise its quarterly dividend by another 13.2 percent to $0.43 per share in 2021. This is the second dividend increase announced by the commercial bank in 2021 for a total hike of 43.3 percent. Chairman and CEO Li Yu commented, “We are very pleased to increase the dividend as it is a direct reflection of the strong performance of the Bank through the pandemic year.” The next PFBC dividend is payable on January 21, 2022 to holders of record on January 7, 2022. The new annual dividend of $1.72 per share translates into an estimated yield of 1.6% for Preferred Bank shareholders at a stock price of $70. Preferred Bank is a commercial bank headquartered in California, conducting its banking business from its main office in Los Angeles, California, and through eleven full-service branch banking offices in California and one branch in Flushing, New York. In addition, the Bank operates a loan production office in the Houston suburb of Sugar Land, Texas. Preferred Ban...

Balchem Corporation (BCPC) will raise its annual dividend by 11.5 percent to 58 cents per share. This marks the 12th consecutive year of annual dividend increases. The new dividend yield for BCPC is 0.4%. Balchem Corporation reports four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications....

Potato products supplier Lamb Weston Holdings Inc. (LW) will raise its quarterly dividend by 4.3 percent to 24.5 cents per share in 2021. This follows a dividend hike of 2.2 percent to 23.5 cents per share in 2020. This marks the 5th year of dividend increases by Lamb Weston, a member of the S&P500-index. The Board of Directors of LW declared a quarterly dividend of $0.245 per share of Lamb Weston common stock, a 4-cent annualized increase. The dividend is payable on March 4, 2022, to stockholders of record as of the close of business on Feb. 4, 2022. A new annualized dividend rate of 98 cents per share yields 1.2% at a stock price of $79. Lamb Weston also authorized to repurchase up to an additional $250 million of its common stock. This is an increase to the initial repurchase program, first approved in December 2018. The program has no expiration date. Two years ago Lamb Weston stated that it will continue to target an annual dividend payout ratio of 25 percent to 35 percent of ...

Mosaic Co (MOS) will raise its quarterly dividend by another 50 percent to 11.25 cents. Earlier in 2021 MOS had already hiked its dividend by 50 percent to 7.5 cents per share. This is the second dividend hike since 2019 by the fertilizer maker and marks 3 consecutive years of increases. The next MOS quarterly dividend will be paid on March 17, 2022, to stockholders of record as of the close of business on March 3, 2022. A new annual rate of 45 cents per share yields 1.2% at a stock price of $36.46. The annual dividend payment by Mosaic will jump to $171 million. The Mosaic Company is a producer and marketer of concentrated phosphate and potash crop nutrients. Mosaic is a single source provider of phosphate and potash fertilizers and feed ingredients for the global agriculture industry. Mosaic operates through three segments: Phosphates, Potash and Mosaic Fertilizantes.

Dividend Aristocrat Realty Income has raised its dividend by 5.1% in 2021 Monthly dividend paying real estate company Realty Income has just announced the 5th increase in 2021. Shareholders will receive a new monthly payment of $0.2465. This year the dividend has been raised by a total of 5.1 percent, based on five smaller dividend hikes.

Bristol-Myers Squibb (BMY) will raise its dividend by 10.2 percent to 54 cents per share quarterly. This comes after a 8.9 percent hike to $0.49 per share announced by BMY in 2021. The pharmaceutical company has now raised its dividend for 14 consecutive years. The next quarterly BMY dividend of 54 cents will be payable on February 1, 2022 to stockholders of record at the close of business on January 7, 2022. A new indicated annual dividend rate of $2.16 per share yields 3.6% at a stock price of $60. Bristol-Myers Squibb now pays an estimated $4.79 billion in dividends to shareholders annually. Dividend growth has been picking up in the last three years, lifting the five year average annualized dividend growth rate to 6.7 percent if we include the 2021 dividend hike just announced. Bristol-Myers Squibb Company is is a global specialty biopharmaceutical company.  Bristol-Myers is developing new medicines in the following core therapeutic areas: oncology with a priority in certain t...

Eli Lilly and Company (LLY) will raise its dividend by 15.3 percent to 98 cents per share. This follows a dividend hike of 14.9 percent to $0.85 per share in the first quarter of 2021. The pharmaceutical company has now raised its dividend for 8 consecutive years. The next LLY dividend is payable March 10, 2022, to shareholders of record as of the close of business on February 15, 2022. The new annual indicated rate to $3.92 per share, yields 1.6% at a stock price of $271.40. Eli Lilly and Company is a manufacturer of human pharmaceutical products. It’s human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. In the U.S., most of Lilly's pharmaceutical products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. Outside the U.S, the company promotes its products to healthcare providers primarily through sales represen...